Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Hidradenitis suppurativa might be a type of autoinflammatory skin disease.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Some Korean herb extracts can reduce inflammation and are safe for skin use.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

People with primary immunodeficiencies often have frequent, severe, or unusual infections and may need special tests and management strategies.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Histone modification is key in treating chronic inflammatory skin diseases.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.